why choose us

First received: March 05, 2026

Clinical Trial: Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pulmonary Hypertension
Rheumatic Valvular Heart Disease

Study Type: INTERVENTIONAL


Official Title: Efficacy of Sildenafil in Severe Pulmonary Hypertension Secondary to Rheumatic Chronic Valvular Disease: A Double-Blinded Placebo Randomized Control Trial

Brief Summary: Pulmonary hypertension secondary to left heart disease is associated with increased morbidity and mortality, particularly in patients with rheumatic chronic valvular heart disease, which remains highly prevalent in low- and middle-income countries. These patients often present late with severe pulmonary hypertension, limiting surgical options and worsening outcomes. Sildenafil, a phosphodiesterase-5 inhibitor, has demonstrated benefit in various forms of pulmonary hypertension; however, its role in pulmonary…

Read more